Fluocinonide

This classification denotes a therapeutic glucocorticoid with the molecular formula C26H32F2O7, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2W4A77YPAN, chemically known as 6.alpha.,9-difluoro-11.beta.,16.alpha., 17,21-tetrahydroxypregna-1,4-diene-3,20-dione, cyclic 16, 17-acetal with acetone, 21-acetate but generally known as fluocinonide, which bears US NIH Compound Identifier 3382. European Medicines Agency schedules Fluocinonide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07715MIG. The term FLUOCINONIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 25 , No. 10 1971, List 11). World Health Organization schedules fluocinonide in its Anatomical Therapeutic Chemical (ATC) Classification. FLUOCINONIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule fluocinonide under HS 29372200 and SITC 54153. As of Q4 2014, FLUOCINONIDE remains the US FDA Preferred Term for this commodity. Fluocinonide bears US NLM identifiers UMLS ID C0016299 and NCI Concept Code C29056. SMILES: FC12C(C3C(C4(OC(OC4C3)(C)C)C(=O)COC(=O)C)(CC1O)C)CC(F)C1=CC(=O)C=CC21C.